tag:blogger.com,1999:blog-36634196.post1228792777879763535..comments2023-10-09T11:33:37.853-05:00Comments on The IN VIVO Blog: DotW: EvolutionChris Morrisonhttp://www.blogger.com/profile/04075266444951558159noreply@blogger.comBlogger1125tag:blogger.com,1999:blog-36634196.post-24307269703516904802009-02-18T16:52:00.000-05:002009-02-18T16:52:00.000-05:00Interesting that little has been noticed regarding...Interesting that little has been noticed regarding one of the most productive Pharma/Academic collaborations, a seven-year diabetes/obesity alliance between Takeda Pharm and Beth Israel Deaconess Medical Center in Boston. BIDMC molecular biology researchers provide novel validated targets that go into HTS at Takeda with the goal of identifying candidate drugs to take the place of Actos, which goes off patent in 2011. It must be working well as the parties have agreed to renew the alliance twice since 2003.Anonymousnoreply@blogger.com